Part B Policies MedPAC Considering Jibe With Trump's Call For Rx Bids

By John Wilkerson / April 5, 2017 at 4:28 PM
Congressional Medicare advisers are scheduled to vote Thursday (April 6) on draft Part B recommendations that will likely include a Drug Value Program with elements that jibe with President Donald Trump's desire for making drug companies bid for government business. Lobbyists are monitoring the Medicare Payment Advisory Commission’s work on Part B drug reimbursement, but they doubt President Donald Trump has taken notice of MedPAC’s work, and some say the president is the lone person in his administration who wants...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.